Population

Bright Health Group to Further Focus on Delivering Affordable Healthcare to Aging and Underserved Populations Through Its Fully Aligned Care Model in Florida, Texas, and California

Retrieved on: 
Tuesday, October 11, 2022
Professional Services, Health, Health Technology, Insurance, Other Health, Health Insurance, Managed Care, Insurance, ACO, Risk, Telephone, SEC, Growth, Bright Health, Population, NYSE, Patient, Partnership, Technology, Form 10-K, Medicare, BHG, Adjustment, Health, CEO, Form, Fullerton Health Group, Forward-looking statement, Ageing, COVID-19, Weather, Health insurance, Family

Further, given the continued solid performance year-to-date, Bright Health Group reaffirms its previous Adjusted EBITDA guidance for 2022 at the midpoint of the range.

Key Points: 
  • Further, given the continued solid performance year-to-date, Bright Health Group reaffirms its previous Adjusted EBITDA guidance for 2022 at the midpoint of the range.
  • We have demonstrated the power of the Fully Aligned Care Model in serving aging and underserved populations and progressed the marketplace towards seeing the promise in value-based care across all populations, said Mike Mikan, President and CEO, Bright Health Group.
  • The changes announced today give Bright Health a strong and stable platform for profitable growth at much lower risk.
  • Bright Health Group will host a conference call to discuss todays announcement with investors at 8:30 a.m. Eastern Time today.

Caris' Precision Oncology Alliance Welcomes The Cancer Institute at The University of Tennessee Medical Center

Retrieved on: 
Tuesday, October 11, 2022
Magnet, Joint Commission, Physician, Trauma center, Disease, POA, Population, Diagnosis, UTMC, Education, FACP, Patient, Intelligence, Drug development, Excellent, University of Tennessee Medical Center, MBA, Twitter, Cancer Institute, ACS, Research, RNA, Woman, Brain, Artificial intelligence, Emergency, Cancer, Knowledge, Perioperative medicine, University, Center, Industry, Blood, Adult, Protein, NICU, University of Maryland Rehabilitation & Orthopaedic Institute, American Securities, DNA, Kimelman Cancer Institute, Database, Medicine, Pharmaceutical industry

IRVING, Texas, Oct. 11, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, announced today that The University of Tennessee Medical Center's (UTMC) Cancer Institute has joined Caris' Precision Oncology Alliance™ (POA). The POA is a growing network of leading cancer centers across the globe that collaborate to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve the clinical outcomes for cancer patients.

Key Points: 
  • "We are proud to join the Caris Precision Oncology Alliance," said John L. Bell, M.D., Director of the Cancer Institute at The University of Tennessee Medical Center.
  • "We're excited to welcome The University of Tennessee Medical Center's Cancer Institute into the growing Caris Precision Oncology Alliance network and look forward to collaborating with its clinicians and investigators to advance clinical and translational research," said Chadi Nabhan , M.D., MBA, FACP, Chairman of the Caris Precision Oncology Alliance.
  • "The University of Tennessee Medical Center's addition to the POA advances our precision oncology research portfolio aiming to improve the outcomes of patients with cancer."
  • UTMC features nine Centers of Excellence, including the Brain & Spine Institute, Cancer Institute, Emergency & Trauma Center, Heart Lung Vascular Institute, Orthopaedic Institute, Center for Complex Medicine, Center for Perioperative Medicine, Primary Care Collaborative and Center for Women & Infants.

RadNet’s Joint Venture, New Jersey Imaging Network, Acquires the Imaging Operations of Montclair Radiology, Expanding its Presence in New Jersey

Retrieved on: 
Tuesday, October 11, 2022
Physician, Health, Population, RadNet, NASDAQ, Patient, Research, MRI, Artificial intelligence, Radiology, Private Securities Litigation Reform Act, Google Images, Information technology, PET/CT, GLOBE, Forward-looking statement, LLP, COVID-19, Mammography, Hospital, Medical imaging, Security (finance)

For more than 75 years, Montclair Radiology has been a leading provider of diagnostic imaging in northern New Jersey, servicing an area encompassing a patient population of 16 million.

Key Points: 
  • For more than 75 years, Montclair Radiology has been a leading provider of diagnostic imaging in northern New Jersey, servicing an area encompassing a patient population of 16 million.
  • Montclair Radiology owns and operates six multimodality centers in Montclair, West Caldwell, Nutley, Verona, Jersey City and Hoboken, providing MRI, CT, PET/CT, x-ray, ultrasound, mammography and other related procedures.
  • Dr. Howard Berger, Chairman and Chief Executive Officer of RadNet, noted, We are pleased to announce this transaction.
  • Our medical group has gained the trustof patients and referring physicians in northern New Jersey by providing exceptional radiology services.

Outlook on the Spirometer Global Market to 2028 - Asia Pacific will Experience the Fastest Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 11, 2022
Medical Devices, Health, Adoption, NHS, News, Time, United States Secretary of Labor, Pulmonary fibrosis, Chronic Respiratory Disease, COPD, Prevalence, Growth, Bronchitis, Population, Smoking, CAGR, Patient, Asthma, Geography, Respiratory system, Urbanization, Technology, Cystic fibrosis, SAU, Degenerative disease, Awareness, World Health Organization, Respiratory disease, Smoker, National Health Service, Atmosphere, App Store (iOS/iPadOS), Agriculture, Pharmaceutical industry, Marketing

The global spirometer market is anticipated to grow at a significant CAGR of 10.2% during the forecast period.

Key Points: 
  • The global spirometer market is anticipated to grow at a significant CAGR of 10.2% during the forecast period.
  • The rising geriatric population is increasing the adoption of a home-based spirometer for the monitoring of chronic respiratory diseases, in turn, fueling the growth of the global spirometer market.
  • Moreover, the rising number of smokers is one of the major drivers of the spirometer market growth.
  • The Asia Pacific is projected to exhibit the fastest growth in the global spirometer market over the forecast period.

Synthetic Rubber Market worth $28.9 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, October 11, 2022
Knowledge, Traction, Milltown Biomass-to-Energy Power Station, FFKM, Transport, Population, Automotive electronics, Houston Wire & Cable, CAGR, Intelligence, Research, Energy, Lubricant, Industry, EV, FKM, Medication, Machine industry, GEM, Footwear, Lists of countries and territories, Challenge, SME, Synthetic, Tire manufacturing, Pet, Oil, Marketing, Automotive industry, Asia-Pacific, Isocyanate, Region, Electronics, Medicine

List of Key Players in Synthetic Rubber Industry:

Key Points: 
  • List of Key Players in Synthetic Rubber Industry:
    Drivers, Restraints, Opportunities and Challenges of Synthetic Rubber Industry:
    Key Findings of the Study:
    1.
  • Tire segment is the fastest growing end use application in the synthetic rubber market.
  • The applications of synthetic rubber in the automotive industry will increase as the EV market gains traction.
  • In Terms of volume and value of the synthetic rubber market in 2022, Asia Pacific region accounts to be the largest market.

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old

Retrieved on: 
Tuesday, October 11, 2022
Dupilumab, Icahn School of Medicine at Mount Sinai, Food, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Health, FDA, Population, UEG, EOE, Weight gain, Ageing, United European Gastroenterology, Pharmaceutical industry

Late-breaking positive results from a Phase 3 trial evaluating the investigational use of Dupixent (dupilumab) in children aged 1 to 11 years with active eosinophilic esophagitis (EoE) will be presented today at United European Gastroenterology (UEG) Week 2022.

Key Points: 
  • Late-breaking positive results from a Phase 3 trial evaluating the investigational use of Dupixent (dupilumab) in children aged 1 to 11 years with active eosinophilic esophagitis (EoE) will be presented today at United European Gastroenterology (UEG) Week 2022.
  • The data will be submitted to regulatory authorities around the world, starting with the U.S. Food and Drug Administration (FDA) in 2023.
  • Rates of treatment discontinuation due to AEs prior to week 16 were 0% (higher dose n=0/37, lower dose n=0/30) for Dupixent and 6% (n=2/34) for placebo.
  • In children, common symptoms of EoE include acid reflux, vomiting, abdominal discomfort, trouble swallowing, and a failure to thrive.

Increased Cycling Events to Propel the Sales in Two Wheeler Accessories Aftermarket, over 60% of The Share to be Acquired by The Protective Gear Category, Says Future Market Insights, Inc.

Retrieved on: 
Tuesday, October 11, 2022
TVS Motor Company, Research report, Motorcycle, Urbanization, Transport, Growth, Population, Yamaha Motor Company, CAGR, KTM, Harley-Davidson, TOC, Partnership, Technology, Haridwar, Consortium, Car, Awareness, Data East USA, Inc. v. Epyx, Inc., Safety, AGV Sports Group, Lists of countries and territories, Projection, YF, Renewable energy, Internet service provider, Medical device, Yamaha Corporation, Pacific Ocean

NEWARK, Del., Oct. 10, 2022 /PRNewswire/ -- During the forecast period 2022-2032, the two wheeler accessories aftermarket is expected to grow at a value of 8.6% CAGR, according to Future Market Insights. By the year 2032, the global market for two wheeler accessories is expected to rise up to a market valuation of US$ 41.07 Bn.

Key Points: 
  • By the year 2032, the global market for two wheeler accessories is expected to rise up to a market valuation of US$ 41.07 Bn.
  • The increased interest in motorcycles and motorbikes has surely created a safe haven for the car sector while also benefiting the two wheeler accessories aftermarket.
  • In 2022, the global two wheeler accessories aftermarket is estimated to have a global market size of US$ 8 Bn.
  • In 2022, the protective gear category by product type is expected to occupy a 65% market share.

Increased Cycling Events to Propel the Sales in Two Wheeler Accessories Aftermarket, over 60% of The Share to be Acquired by The Protective Gear Category, Says Future Market Insights, Inc.

Retrieved on: 
Tuesday, October 11, 2022
TVS Motor Company, Research report, Motorcycle, Urbanization, Transport, Growth, Population, Yamaha Motor Company, CAGR, Harley-Davidson, TOC, Partnership, Technology, Haridwar, Consortium, Car, Awareness, Data East USA, Inc. v. Epyx, Inc., Safety, AGV Sports Group, Lists of countries and territories, Projection, YF, Renewable energy, Internet service provider, Medical device, Yamaha Corporation, Pacific Ocean

NEWARK, Del., Oct. 10, 2022 /PRNewswire/ -- During the forecast period 2022-2032, the two wheeler accessories aftermarket is expected to grow at a value of 8.6% CAGR, according to Future Market Insights. By the year 2032, the global market for two wheeler accessories is expected to rise up to a market valuation of US$ 41.07 Bn.

Key Points: 
  • By the year 2032, the global market for two wheeler accessories is expected to rise up to a market valuation of US$ 41.07 Bn.
  • The increased interest in motorcycles and motorbikes has surely created a safe haven for the car sector while also benefiting the two wheeler accessories aftermarket.
  • In 2022, the global two wheeler accessories aftermarket is estimated to have a global market size of US$ 8 Bn.
  • In 2022, the protective gear category by product type is expected to occupy a 65% market share.

Controlled Release Fertilizers Market to Garner $4.3 Billion, Globally, By 2031 at 6.6% CAGR, Says Allied Market Research

Retrieved on: 
Tuesday, October 11, 2022
Globe, Movement, Growth, Population, Electricity, Soil, Mode, CAGR, Farmer, Leaf, Fertilizer, Investment, Industry, Water, Awareness, Food, Environment, COVID-19, Agriculture, Nitrogen, Fertigation, Coating

PORTLAND, Ore., Oct. 10, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Controlled Release Fertilizers Market by Type (Slow Release, Nitrogen stabilizers, Coated and encapsulated), by Mode of Application (Foliar, Fertigation, Soil, Others), by End Use (Agricultural, Non-agricultural): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global controlled release fertilizers industry is estimated to generate $2.3 billion in 2021 and $4.3 billion by 2031, witnessing a CAGR of 6.6% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Key Points: 
  • Growing demand for agricultural products across the globe, rise in penetration of controlled and slow-release fertilizers, negative effects of conventional fertilizers on the environment, and the need for control fertilizers to enhance crop yield drive the global controlled release fertilizers market.
  • PORTLAND, Ore., Oct. 10, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Controlled Release Fertilizers Market by Type (Slow Release, Nitrogen stabilizers, Coated and encapsulated), by Mode of Application (Foliar, Fertigation, Soil, Others), by End Use (Agricultural, Non-agricultural): Global Opportunity Analysis and Industry Forecast, 2021-2031."
  • According to the report, the global controlled release fertilizers industry is estimated to generate $2.3 billion in 2021 and $4.3 billion by 2031, witnessing a CAGR of 6.6% from 2022 to 2031.
  • The controlled release fertilizers market was negatively influenced by the COVID-19 outbreak, owing to governments' restrictions on import & export of controlled release fertilizers and their distribution of fertilizers across the globe.

Controlled Release Fertilizers Market to Garner $4.3 Billion, Globally, By 2031 at 6.6% CAGR, Says Allied Market Research

Retrieved on: 
Tuesday, October 11, 2022
Globe, Movement, Growth, Population, Electricity, Soil, Mode, CAGR, Farmer, Leaf, Fertilizer, Investment, Industry, Water, Awareness, Food, Environment, COVID-19, Agriculture, Nitrogen, Fertigation, Coating

PORTLAND, Ore., Oct. 10, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Controlled Release Fertilizers Market by Type (Slow Release, Nitrogen stabilizers, Coated and encapsulated), by Mode of Application (Foliar, Fertigation, Soil, Others), by End Use (Agricultural, Non-agricultural): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global controlled release fertilizers industry is estimated to generate $2.3 billion in 2021 and $4.3 billion by 2031, witnessing a CAGR of 6.6% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Key Points: 
  • Growing demand for agricultural products across the globe, rise in penetration of controlled and slow-release fertilizers, negative effects of conventional fertilizers on the environment, and the need for control fertilizers to enhance crop yield drive the global controlled release fertilizers market.
  • PORTLAND, Ore., Oct. 10, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Controlled Release Fertilizers Market by Type (Slow Release, Nitrogen stabilizers, Coated and encapsulated), by Mode of Application (Foliar, Fertigation, Soil, Others), by End Use (Agricultural, Non-agricultural): Global Opportunity Analysis and Industry Forecast, 2021-2031."
  • According to the report, the global controlled release fertilizers industry is estimated to generate $2.3 billion in 2021 and $4.3 billion by 2031, witnessing a CAGR of 6.6% from 2022 to 2031.
  • The controlled release fertilizers market was negatively influenced by the COVID-19 outbreak, owing to governments' restrictions on import & export of controlled release fertilizers and their distribution of fertilizers across the globe.